Investigating the effect of bromelain in patients with covid-19

Phase 3

• Conditions: COVID-19.; COVID-19, virus identified; U07.02

• Registration Number: IRCT20150725023332N6
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Age 18-70 years
Patient consciousness
Consent to enter the study

Exclusion Criteria

kidney and liver diseases
corticosteroid uses in the last two weeks
sensitivity to pineapple and bromelain drug
hospitalization in IC

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
WBC. Timepoint: Before and after receiving the drug. Method of measurement: Cell counting.;The number of lymphocytes. Timepoint: Before and after receiving the drug. Method of measurement: Cell counting.;The number of neutrophils. Timepoint: Before and after receiving the drug. Method of measurement: Cell counting.;ESR. Timepoint: Before and after receiving the drug. Method of measurement: Sadiman Reader.;CRP. Timepoint: Before and after receiving the drug. Method of measurement: Biochemical test.;IL-6. Timepoint: Before and after receiving the drug. Method of measurement: Biochemical test.;TNFa. Timepoint: Before and after receiving the drug. Method of measurement: Biochemical test.